vimarsana.com

Latest Breaking News On - Institutional trading of eyepoint pharmaceuticals - Page 1 : vimarsana.com

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $11.16

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report)’s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $11.16, but opened at $10.90. EyePoint Pharmaceuticals shares last traded at $11.13, with a volume of 79,034 shares. Analyst Ratings Changes Several research analysts have recently issued reports on the company. […]

Davidr-guyer
Robertw-baird
Institutional-trading-of-eyepoint-pharmaceuticals
Securities-exchange-commission
Eyepoint-pharmaceuticals-inc
Eyepoint-pharmaceuticals-company-profile
Mirae-asset-global-investments-co
Eyepoint-pharmaceuticals-stock
News-ratings-for-eyepoint-pharmaceuticals-daily
Deutsche-bank
Investment-advisers

EyePoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by StockNews.com

EyePoint Pharmaceuticals (NASDAQ:EYPT) Downgraded by StockNews.com
modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.

Robertw-baird
Jennison-associates
Institutional-trading-of-eyepoint-pharmaceuticals
Franklin-resources-inc
First-turn-management
Eyepoint-pharmaceuticals-company-profile
Eyepoint-pharmaceuticals-inc
Securities-exchange-commission
Hermes-inc
Eyepoint-pharmaceuticals
Analyst-recommendations-for-eyepoint-pharmaceuticals

EyePoint Pharmaceuticals (NASDAQ:EYPT) PT Lowered to $38.00

EyePoint Pharmaceuticals (NASDAQ:EYPT) PT Lowered to $38.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China
Robertw-baird
Tower-research-capital
Eyepoint-pharmaceuticals-trading
Eyepoint-pharmaceuticals-inc
Analyst-recommendations-for-eyepoint-pharmaceuticals
Jpmorgan-chase-co
Institutional-trading-of-eyepoint-pharmaceuticals
Eyepoint-pharmaceuticals
Toth-financial-advisory-corp
News-ratings-for-eyepoint-pharmaceuticals-daily

Insider Selling: EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Insider Sells 49,325 Shares of Stock

Insider Selling: EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Insider Sells 49,325 Shares of Stock
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

China
Darioa-paggiarino
News-ratings-for-eyepoint-pharmaceuticals-daily
Lazard-asset-management
Jpmorgan-chase-co
Quarter-for-eyepoint-pharmaceuticals
Nasdaq
Eyepoint-pharmaceuticals-inc
Institutional-trading-of-eyepoint-pharmaceuticals
China-universal-asset-management-co
Investment-advisers

EyePoint Pharmaceuticals (NASDAQ:EYPT) Coverage Initiated by Analysts at JPMorgan Chase & Co.

JPMorgan Chase & Co. began coverage on shares of EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) in a research note published on Monday morning, Marketbeat.com reports. The firm issued an overweight rating and a $35.00 target price on the stock. A number of other research analysts have also recently issued reports on the company. Capital One […]

China
Darioa-paggiarino
Dekabank-deutsche-girozentrale
Woodstock-corp
Mirae-asset-global-investments-co
Securities-exchange-commission
Nasdaq
Eyepoint-pharmaceuticals-inc
Analyst-recommendations-for-eyepoint-pharmaceuticals
Jpmorgan-chase-co
Institutional-trading-of-eyepoint-pharmaceuticals
China-universal-asset-management-co

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.